Research and application of NVP-BEZ235 in lung cancer

Xiaoyu Chai,Meng Xu,Xinmin Liu
DOI: https://doi.org/10.3760/cma.j.issn.1673-422X.2017.05.015
2017-01-01
Abstract:NVP-BEZ235 is a newly developed dual phosphatidyl linositol kinase 3-kinase (PI3K) and mammalian target of rapamycin (mTOR) inhibitor.Studies have revealed that NVP-BEZ235 combinate with other drugs were effective in the treatment of lung cancer.NVP-BEZ235 might have a potential application value for the treatment of lung cancer of EGFR mutation subtype and KRAS mutation subtype.
What problem does this paper attempt to address?